Metraipolis › archive › dc_0bad1cd9879a

IL-6 Blockade Enhances the Efficacy of CDK4/6 Inhibitor in BRCA1-Mutant Triple-Negative Breast Cancer Cells — Europe PMC PMID:41148817

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41148817
DOI
10.3390/cells14201602
License (as archived)
solo-consultazione
Archived
2026-11-09T07:23:55.081Z
SHA-256 of the archived text
d96e694d89e1841e292a1fa438bd2bf614284c20b518a3d9b47e73b1b7d6a6e1
Stable URL of this page
https://metraipolis.com/documento/dc_0bad1cd9879a

How to cite

IL-6 Blockade Enhances the Efficacy of CDK4/6 Inhibitor in BRCA1-Mutant Triple-Negative Breast Cancer Cells — Europe PMC PMID:41148817 — Europe PMC (en), https://europepmc.org/article/MED/41148817 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0bad1cd9879a (Metraipolis archive dc_0bad1cd9879a, sha256 d96e694d89e1841e292a1fa438bd2bf614284c20b518a3d9b47e73b1b7d6a6e1)
BibTeX
@misc{dc0bad1cd9879a,
  title = {IL-6 Blockade Enhances the Efficacy of CDK4/6 Inhibitor in BRCA1-Mutant Triple-Negative Breast Cancer Cells — Europe PMC PMID:41148817},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41148817},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0bad1cd9879a; sha256 d96e694d89e1841e292a1fa438bd2bf614284c20b518a3d9b47e73b1b7d6a6e1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41148817. Agents can read the archived copy with the MCP tool read_document.